Detection of TT virus in lymph node biopsies of B-cell lymphoma and Hodgkin's disease, and its association with EBV infection.

Isolation of multiple TT virus genotypes from spleen biopsy tissue from a Hodgkin's disease patient: genome reorganization and diversity in the hypervariable region. J Virol (2004) 1.04

The diversity of torque teno viruses: in vitro replication leads to the formation of additional replication-competent subviral molecules. J Virol (2011) 1.04

Endogenous retroviral pathogenesis in lupus. Curr Opin Rheumatol (2010) 0.95

Molecular mimicry and immunomodulation by the HRES-1 endogenous retrovirus in SLE. Autoimmunity (2008) 0.93

Variable frequency of polyomavirus SV40 and herpesvirus EBV in lymphomas from two different urban population groups in Houston, TX. J Clin Virol (2009) 0.90

In vivo and in vitro intragenomic rearrangement of TT viruses. J Virol (2007) 0.90

Torque teno virus 10 isolated by genome amplification techniques from a patient with concomitant chronic lymphocytic leukemia and polycythemia vera. Mol Med (2011) 0.88

Torque teno virus (SANBAN isolate) ORF2 protein suppresses NF-kappaB pathways via interaction with IkappaB kinases. J Virol (2007) 0.87

TT virus infection and pancreatic cancer: relationship or accidental coexistence. World J Gastroenterol (2005) 0.87

Identification of a new genotype of Torque Teno Mini virus. Virol J (2013) 0.84

Epstein-Barr virus stimulates torque teno virus replication: a possible relationship to multiple sclerosis. PLoS One (2012) 0.80

High co-prevalence of genogroup 1 TT virus and human papillomavirus is associated with poor clinical outcome of laryngeal carcinoma. J Clin Pathol (2005) 0.80

Study of the Associations Between TT Virus Single and Mixed Infections With Leukemia. Jundishapur J Microbiol (2015) 0.75

The presence of Torque teno virus in chronic obstructive pulmonary disease. Int J Clin Exp Med (2014) 0.75

Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups. N Engl J Med (1995) 4.19

Measles outbreak on a cruise ship in the western Mediterranean, February 2014, preliminary report. Euro Surveill (2014) 3.87

Clinical outcome of extramedullary plasmacytoma. Haematologica (2000) 3.27

Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups. Blood (2000) 3.07

The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. N Engl J Med (1997) 2.41

Spontaneous release of interferon gamma by intestinal lamina propria lymphocytes in Crohn's disease. Kinetics of in vitro response to interferon gamma inducers. Gut (1991) 2.21

Early deaths and anti-hemorrhagic treatments in acute promyelocytic leukemia. A GIMEMA retrospective study in 268 consecutive patients. Blood (1990) 2.04

A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. AML Cooperative Study Group. N Engl J Med (1995) 1.94

Coccoid Helicobacter pylori not culturable in vitro reverts in mice. Microbiol Immunol (1994) 1.79

Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features. Blood (2000) 1.79

The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study. Haematologica (1998) 1.66

Granulocytic sarcoma with breast and skin presentation: a report of a case successfully treated by local radiation and systemic chemotherapy. Acta Haematol (2000) 1.66

Epstein-Barr virus infection is predictive of CNS involvement in systemic AIDS-related non-Hodgkin's lymphomas. J Clin Oncol (2000) 1.55

Anaplastic large-cell lymphoma: clinical and prognostic evaluation of 90 adult patients. J Clin Oncol (1996) 1.54

Melphalan treatment in patients with myelofibrosis with myeloid metaplasia. Br J Haematol (2002) 1.52

The European network of Biosafety-Level-4 laboratories: enhancing European preparedness for new health threats. Clin Microbiol Infect (2009) 1.52

Idiopathic thrombocytopenic purpura (ITP) in the elderly: clinical course in 178 patients. Eur J Haematol (2006) 1.50

Alterations of the FLT3 gene in acute promyelocytic leukemia: association with diagnostic characteristics and analysis of clinical outcome in patients treated with the Italian AIDA protocol. Leukemia (2002) 1.49

Solitary plasmacytoma of bone and extramedullary plasmacytoma: two different entities? Ann Oncol (1995) 1.49

Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDS. Blood (2001) 1.48

Granulocyte-macrophage colony-stimulating factor associated with induction treatment of acute myelogenous leukemia: a randomized trial by the European Organization for Research and Treatment of Cancer Leukemia Cooperative Group. J Clin Oncol (1996) 1.47

Hepatitis C virus treatment revolution: need for close monitoring. Clin Microbiol Infect (2014) 1.43

Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid: a report by the Gruppo Italiano Malattie Ematologiche dell'Adulto. J Clin Oncol (2001) 1.43

Detection of haemagglutinin D222 polymorphisms in influenza A(H1N1)pdm09-infected patients by ultra-deep pyrosequencing. Clin Microbiol Infect (2012) 1.41

Regulation of TCL1 expression in B- and T-cell lymphomas and reactive lymphoid tissues. Cancer Res (2000) 1.40

A prospective study of alpha-interferon and autologous bone marrow transplantation in chronic myeloid leukemia. The Italian Co-operative Study Group on Chronic Myeloid Leukemia. Haematologica (1999) 1.39

Recombinant alpha 2b interferon (alpha-2b-IFN), chlorambucil, and prednisone in advanced chronic lymphocytic leukemia (CLL) Eur J Haematol (1991) 1.39

Surgical approach to isolated mediastinal lymphoma. J Thorac Cardiovasc Surg (1990) 1.39

Occurrence of thrombotic events in acute promyelocytic leukemia correlates with consistent immunophenotypic and molecular features. Leukemia (2006) 1.38

Reversal of iron deficiency anemia after Helicobacter pylori eradication in patients with asymptomatic gastritis. Ann Intern Med (1999) 1.38

Prolonged suppression of myeloid progenitor cell numbers after stopping interferon treatment for CML may necessitate delay in harvesting marrow cells for autografting. Bone Marrow Transplant (1990) 1.38

Interferon therapy for Ph1 positive CML patients relapsing after T cell-depleted allogeneic bone marrow transplantation. Bone Marrow Transplant (1990) 1.38

Unidirectional budding of HIV-1 at the site of cell-to-cell contact is associated with co-polarization of intercellular adhesion molecules and HIV-1 viral matrix protein. AIDS (1995) 1.37

The incidence of secondary leukemias. Haematologica (1999) 1.36

miR-204 targets Bcl-2 expression and enhances responsiveness of gastric cancer. Cell Death Dis (2012) 1.33

AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) pilot study. Blood (1996) 1.31

Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study Group. Lancet (1994) 1.29

p53 expression in B-cell chronic lymphocytic leukemia: a marker of disease progression and poor prognosis. Blood (1998) 1.28

Early detection of relapse by prospective reverse transcriptase-polymerase chain reaction analysis of the PML/RARalpha fusion gene in patients with acute promyelocytic leukemia enrolled in the GIMEMA-AIEOP multicenter "AIDA" trial. GIMEMA-AIEOP Multicenter "AIDA" Trial. Blood (1998) 1.28

Treatment and clinical management of primary mediastinal large B-cell lymphoma with sclerosis: MACOP-B regimen and mediastinal radiotherapy monitored by (67)Gallium scan in 50 patients. Blood (1999) 1.27

Early haemorrhagic morbidity and mortality during remission induction with or without all-trans retinoic acid in acute promyelocytic leukaemia. Br J Haematol (2000) 1.26

Group B coxsackieviruses readily establish persistent infections in human lymphoid cell lines. J Virol (1985) 1.24

Acute megakaryoblastic leukemia: experience of GIMEMA trials. Leukemia (2002) 1.22

Multinucleated giant cells generation induced by interferon-gamma. Changes in the expression and distribution of the intercellular adhesion molecule-1 during macrophages fusion and multinucleated giant cell formation. Lab Invest (1994) 1.22

The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-GIMEMA AML-10 trial. Leukemia (2003) 1.21

Expression of cellular oncogenes in primary cells from human acute leukemias. Proc Natl Acad Sci U S A (1986) 1.20

Fungemia in patients with leukemia. Am J Med Sci (1993) 1.19

Catheter-related right-sided endocarditis in bone marrow transplant recipients. Rev Infect Dis (1990) 1.18

Neutropenic enterocolitis in patients with acute leukemia: prognostic significance of bowel wall thickening detected by ultrasonography. J Clin Oncol (2001) 1.18

Expression of HIV in lymph node cells of LAS patients. Immunohistology, in situ hybridization, and identification of target cells. Am J Pathol (1988) 1.16

Long-term survival in childhood acute lymphocytic leukemia in Italy. Cancer (1981) 1.16

Clinical characteristics and outcome of young chronic lymphocytic leukemia patients: a single institution study of 204 cases. Blood (1999) 1.15

Bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: importance of a graft-versus-leukaemia effect. Br J Haematol (1988) 1.14

Hospital-acquired cryptosporidiosis in a bone marrow transplantation unit. J Infect Dis (1988) 1.12

Investigating factors associated with adherence behaviour in patients with chronic myeloid leukemia: an observational patient-centered outcome study. Br J Cancer (2012) 1.11

Primary cutaneous plasmacytoma: report of a case with review of the literature. J Am Acad Dermatol (2000) 1.11

The A-Myb transcription factor is a marker of centroblasts in vivo. J Immunol (1998) 1.10

NK/T-cell lymphomas 'nasal type': an Italian multicentric retrospective survey. Ann Oncol (2006) 1.10

Significant reduction of the hybrid BCR/ABL transcripts after induction and consolidation therapy is a powerful predictor of treatment response in adult Philadelphia-positive acute lymphoblastic leukemia. Leukemia (2005) 1.10

Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT. Ann Oncol (2006) 1.09

Differences in the expression and release of DR, BR, and DQ molecules in human cells treated with recombinant interferon gamma: comparison to other interferons. Hum Immunol (1985) 1.09

Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin's lymphoma: an Italian multicenter randomized trial. J Clin Oncol (2003) 1.09

Infant acute leukemias show the same biased distribution of ALL1 gene breaks as topoisomerase II related secondary acute leukemias. Cancer Res (1997) 1.09

HLA-D region antigens on isolated human colonic epithelial cells: enhanced expression in inflammatory bowel disease and in vitro induction by different stimuli. Clin Exp Immunol (1988) 1.08

A specific monoclonal antibody (PG-B6) detects expression of the BCL-6 protein in germinal center B cells. Am J Pathol (1995) 1.07

Induction of interleukin-10 by human immunodeficiency virus type 1 and its gp120 protein in human monocytes/macrophages. J Virol (1995) 1.07

Primary plasma cell leukemia: a retrospective multicenter study of 73 patients. Ann Oncol (2011) 1.07

Acute lymphoblastic leukaemia occurring as second malignancy: report of the GIMEMA archive of adult acute leukaemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. Br J Haematol (1999) 1.07

Human interferon-gamma enhances the expression of class I and class II major histocompatibility complex products in neoplastic cells more effectively than interferon-alpha and interferon-beta. Infect Immun (1983) 1.06

Analysis of co-receptor usage of circulating viral and proviral HIV genome quasispecies by ultra-deep pyrosequencing in patients who are candidates for CCR5 antagonist treatment. Clin Microbiol Infect (2010) 1.06

Alpha interferon inhibits human herpesvirus 8 (HHV-8) reactivation in primary effusion lymphoma cells and reduces HHV-8 load in cultured peripheral blood mononuclear cells. J Virol (1999) 1.04

Obesity and autologous stem cell transplantation in acute myeloid leukemia. Bone Marrow Transplant (2001) 1.04

Good steroid response in vivo predicts a favorable outcome in children with T-cell acute lymphoblastic leukemia. The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP). Cancer (1995) 1.03

Polymorphonuclear leukocyte transfusion for the treatment of sepsis in the newborn infant. J Pediatr (1981) 1.02

Chronic fatigue is the most important factor limiting health-related quality of life of chronic myeloid leukemia patients treated with imatinib. Leukemia (2013) 1.01

Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche dell' Adulto. Clin Infect Dis (1999) 1.01

HIV type 1 grown on interferon gamma-treated U937 cells shows selective increase in virion-associated intercellular adhesion molecule 1 and HLA-DR and enhanced infectivity for CD4-negative cells. AIDS Res Hum Retroviruses (1995) 1.01

Distinctive expression pattern of the BCL-6 protein in nodular lymphocyte predominance Hodgkin's disease. Blood (1996) 1.00

Co-localization of multiple ErbB receptors in stratified epithelium of oral squamous cell carcinoma. J Pathol (2001) 1.00

Acute promyelocytic leukemia: clinical and morphologic features and prognostic factors. Semin Hematol (2001) 1.00

Recombinant gp120 induces IL-10 in resting peripheral blood mononuclear cells; correlation with the induction of other cytokines. Clin Exp Immunol (1994) 1.00

Interferon induction by HIV glycoprotein 120: role of the V3 loop. Virology (1994) 0.99

The role of high resolution pulsed and color Doppler ultrasound in the differential diagnosis of benign and malignant lymphadenopathy: results of multivariate analysis. Cancer (1999) 0.99

Mosaicism for sulfoiduronate sulfatase deficiency in carriers of Hunter's syndrome. Experientia (1976) 0.99

Adolescent and adult acute lymphoblastic leukemia: prognostic features and outcome of therapy. A study of 293 patients. Blood (1982) 0.98

Interferon expression in Crohn's disease patients: increased interferon-gamma and -alpha mRNA in the intestinal lamina propria mononuclear cells. J Interferon Res (1994) 0.98

Immune tolerance induction with a high purity von Willebrand factor/VIII complex concentrate in haemophilia A patients with inhibitors at high risk of a poor response. Haemophilia (2007) 0.97

Hair dye use and other risk factors for leukemia and pre-leukemia: a case-control study. Italian Leukemia Study Group. Am J Epidemiol (1994) 0.97

A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropenia. Clin Infect Dis (2001) 0.97

Serum IL-10 levels in HIV-positive subjects: correlation with CDC stages. J Biol Regul Homeost Agents (1995) 0.97

Are patients with acute leukaemia, alive and well 2 years post bone marrow transplantation cured? A European survey. Acute Leukaemia Working Party of the European Group for Bone Marrow Transplantation (EBMT). Leukemia (1994) 0.97

Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formol-resistant epitope on the human BCL-6 protein amino-terminal region. Am J Pathol (1996) 0.97